A phase I study evaluating COM701 in patients with advanced solid tumors.

被引：0
|
作者：
Rasco, Drew W.
Vaena, Daniel A.
Sullivan, Ryan J.
Luke, Jason J.
ElNaggar, Adam
Hunter, John
Adewoye, Adeboye H.
Olweny, Judy
Patnaik, Amita
Hamilton, Erika Paige
机构：
[1] START, San Antonio, TX USA
[2] West Canc Ctr, Memphis, TN USA
[3] Massachusetts Gen Hosp, Boston, MA 02114 USA
[4] Univ Chicago, Ctr Comprehens Canc, Chicago, IL 60637 USA
[5] Compugen USA Inc, San Francisco, CA USA
[6] Tennessee Oncol PLLC, Nashville, TN USA
[7] Sarah Cannon Res Inst, Nashville, TN USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2019年 / 37卷 / 15期
关键词：
D O I：
10.1200/JCO.2019.37.15_suppl.TPS2657
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
TPS2657
引用
收藏
页数：1
相关论文
共 50 条
  • [41] A phase I dose escalation and pharmacodynamic study of weekly administered AlbuleukinTM in patients with advanced solid tumors.
    Agarwala, SS
    Bukowski, RM
    Kirkwood, J
    Weiss, P
    Olencki, T
    Grzegorewski, KJ
    Melder, R
    Fox, RA
    Herpst, JM
    Gallant, G
    CLINICAL CANCER RESEARCH, 2003, 9 (16) : 6230S - 6231S
  • [42] Phase I pharmacokinetic (PK) study of daily imatinib in combination with docetaxel for patients with advanced solid tumors.
    Chatta, GS
    Fakih, M
    Ramalingam, S
    Belani, CP
    Ramanathan, RK
    Zamboni, N
    Friedland, D
    Lis, D
    Tutchko, S
    Egorin, M
    JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (14) : 138S - 138S
  • [43] A phase I study of MK-2206 in combination with lapatinib in patients (pts) with advanced solid tumors.
    Wisinski, Kari Braun
    Tevaarwerk, Amye
    Bell, Maria
    Burkard, Mark E.
    Eickhoff, Jens C.
    Wilding, George
    LoConte, Noelle K.
    Traynor, Anne M.
    Hoang, Tien
    Heideman, Jennifer
    Kolesar, Jill
    Liu, Glenn
    JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (15)
  • [44] A phase I study of a novel IAP inhibitor APG-1387 in patients with advanced solid tumors.
    Xu, Ruihua
    Li, Yuhong
    Ji, Jiao
    Qiu, Miaozhen
    Zhang, Yang
    Liu, Wenqin
    Tian, Xiaohong
    Li, Su
    Wang, Hengbang
    Wang, Fenghua
    Zhang, Dongsheng
    Wang, Feng
    Wang, Zhiqiang
    Luo, Huiyan
    Zou, Benyan
    Wang, De shen
    Ren, Chao
    Jin, Ying
    Zhai, Yifan
    Yang, Dajun
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (15)
  • [45] A phase I study of safety and pharmacokinetics of NanoBB-1-Dox in patients with advanced solid tumors.
    Filon, Olga
    Krivorotko, Petr
    Kobyakov, Grigory
    Razjivina, Viktoria
    Maximenko, Olga
    Gelperina, Svetlana
    Kreuter, Joerg
    JOURNAL OF CLINICAL ONCOLOGY, 2017, 35
  • [46] Phase I study of CFI-402257, an oral TTK inhibitor, in patients with advanced solid tumors.
    Cescon, David W.
    Hansen, Aaron Richard
    Razak, Albiruni Ryan Abdul
    Stayner, Lee-Anne
    Hilton, John Frederick
    Renouf, Daniel John
    Denny, Trisha
    Fletcher, Graham
    Mak, Tak W.
    Bray, Mark R.
    Bedard, Philippe L.
    JOURNAL OF CLINICAL ONCOLOGY, 2017, 35
  • [47] Phase I study of ispinesib (SB-715992) in combination with docetaxel in patients with advanced solid tumors.
    Blagden, S
    Seebaran, A
    Molife, R
    Payne, M
    Reid, A
    Protheroe, A
    Kathman, S
    Williams, D
    Bowen, C
    Hodge, J
    Dar, M
    de-Bono, J
    Middleton, M
    CLINICAL CANCER RESEARCH, 2005, 11 (24) : 9119S - 9119S
  • [48] Phase I study of ispinesib (SB-715992) in combination with capecitabine in patients with advanced solid tumors.
    Calvo, E
    Chu, Q
    Till, E
    Rowinsky, EK
    Patnaik, A
    Takimoto, C
    Kathman, SJ
    Williams, DD
    Bowen, CJ
    Hodge, JP
    Dar, MM
    Tolcher, AW
    CLINICAL CANCER RESEARCH, 2005, 11 (24) : 9120S - 9120S
  • [49] A phase I study of doxorubicin in horses with advanced tumors.
    Theon, A. P.
    Magdesian, G. K.
    Pusterla, N.
    Wilson, W. D.
    JOURNAL OF VETERINARY INTERNAL MEDICINE, 2007, 21 (03) : 667 - 667
  • [50] Phase I trial of Amplimexon™ (imexon, inj.) in patients with advanced solid tumors.
    Dragovich, T
    Mendelson, D
    Gordon, M
    Wong, L
    Dorr, R
    Chow, S
    Grenier, K
    Hersh, E
    CLINICAL CANCER RESEARCH, 2005, 11 (24) : 9122S - 9122S
12345